DHR vs SBUX: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Starbucks Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-10.
Danaher Corporation · Healthcare
$195.98
+7.9% upside to fair value
Grade B
High Quality
VS
Starbucks Corporation · Consumer Cyclical
$100.65
-6.1% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+7.9%).
DHR trades at a lower forward P/E
(37.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
SBUX |
| Current Price |
$195.98 |
$100.65 |
| Fair Value Estimate |
$211.54 |
$94.50 |
| Upside to Fair Value |
+7.9%
|
-6.1%
|
| Market Cap |
$138.7B |
$114.7B |
| Forward P/E |
37.8x
|
76.7x
|
| EV / EBITDA |
22.8x
|
25.6x
|
| Price / Sales |
5.6x
|
3.0x
|
| Price / FCF |
26.2x
|
42.1x
|
| Revenue Growth YoY |
+3.7%
|
+8.8%
|
| Gross Margin |
60.7%
|
20.4%
|
| Operating Margin |
21.0%
|
9.3%
|
| Return on Equity |
7.1%
|
-18.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.81%
|
2.38%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher Corporation operates in the healthcare sector, specifically in medical diagnostics and research, delivering high-quality products with a durable competitive moat supported by strong margins and consistent earnings growth. The company trades at a trailing and forward P/E of 37.76, which is relatively high but justified by its stable revenue growth of 3.7% and earnings growth of 7.9% in the…
Starbucks Corporation operates a global coffeehouse chain with a strong brand and a leading digital/mobile platform, serving approximately 90 million customers weekly through over 28,000 stores in 77 countries. The company benefits from a durable competitive moat based on its extensive store footprint, brand recognition, and digital engagement rather than proprietary products. Despite solid reven…
Accumulation Zones
| Metric |
DHR |
SBUX |
| Zone Low |
$158.66 |
$70.88 |
| Zone High |
$179.81 |
$80.33 |
| In Buy Zone? |
No
|
No
|